A prospective, multicenter, non-randomized observational study assessing the duration of fever and symptoms of influenza A/H1N1pdm09 and A/H3N2 infected children treated with either Baloxavir or Oseltamivir
Latest Information Update: 30 Jul 2021
At a glance
- Drugs Baloxavir-marboxil (Primary) ; Oseltamivir (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza A virus H3N2 subtype
- Focus Therapeutic Use
- Acronyms 2018-0317
- 30 Jul 2021 New trial record